Volume 50, Issue 11 pp. 3663-3667
Research Article

Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation

Thomas Stabler

Thomas Stabler

Duke University Medical Center, Durham, NC

Search for more papers by this author
Jean-Charles Piette

Jean-Charles Piette

Pitié-Salpêtrière University Hospital, Paris, France

Search for more papers by this author
Xavier Chevalier

Xavier Chevalier

Henri Mondor University Hospital, Crèteil, France

Search for more papers by this author
Andre Marini-Portugal

Andre Marini-Portugal

Henri Mondor University Hospital, Crèteil, France

Search for more papers by this author
Virginia B. Kraus

Corresponding Author

Virginia B. Kraus

Duke University Medical Center, Durham, NC

Department of Medicine, Duke University Medical Center, Box 3416, Durham, NC 27710Search for more papers by this author
First published: 04 November 2004
Citations: 121

Abstract

Objective

There is evidence that autoimmunity plays a significant role in the pathogenesis of relapsing polychondritis (RP). This study was designed to investigate circulating levels of various cytokines in relation to the etiology of this rare disorder, and to compare the pattern of cytokine elevations in RP with that in another autoimmune disease, rheumatoid arthritis (RA).

Methods

Serum from 22 patients with active RP and an equal number of age- and sex-matched healthy controls and RA patients were available for analysis. The following cytokines were measured: interleukin-1β (IL-1β), IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17, interferon-γ (IFNγ), tumor necrosis factor α, granulocyte colony-stimulating factor (G-CSF), granulocyte–macrophage colony-stimulating factor (GM-CSF), monocyte chemoattractant protein 1 (MCP-1), and macrophage inflammatory protein 1β (MIP-1β). Results were analyzed by nonparametric Mann-Whitney test with Holm stepdown adjustment for multiple testing.

Results

The levels of 3 of these cytokines showed significant differences between RP patients and controls. Compared with controls, mean serum levels of MCP-1, MIP-1β, and IL-8 were all much higher in patients with active RP. In contrast, RA patients showed a more general increase in all cytokines measured, with much higher levels of IL-2, IL-4, IL-5, IL-6, IL-7, IL-10, IL-13, IFNγ, G-CSF, GM-CSF, MCP-1, and MIP-1β compared with controls.

Conclusion

Levels of 3 serum cytokines were significantly higher in RP patients than in age- and sex-matched controls. One of these 3 cytokines, IL-8, was not significantly elevated in RA samples. Overall, in RP, a more discrete group of cytokines exhibited significantly increased levels than was found in RA. Each of the 3 cytokines that were elevated in RP is a proinflammatory chemokine, characteristic of activation of the monocyte and macrophage lineage, and in the case of IL-8, also of neutrophils. These data suggest a major role for a cell-mediated immune response in the pathophysiology of RP.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me